bioAffinity Technologies, Inc. Common Stock (BIAF) Stock Price, Quote & AI Analysis
Live BIAF stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for bioAffinity Technologies, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for bioAffinity Technologies, Inc. Common Stock (BIAF), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
bioAffinity Technologies, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
bioAffinity Technologies, Inc. Common Stock Overview
Company information
Company Overview
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
bioAffinity Technologies, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...